Gene Expression for Compartment Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand why some people develop compartment syndrome after a serious leg injury while others do not. Researchers will examine genetic and gene expression differences between those with and without compartment syndrome, as well as those with exertional compartment syndrome planning surgery. This trial may suit individuals who have recently experienced a severe leg fracture or are dealing with exertional compartment syndrome and are ready for surgery.
As an unphased trial, participants can contribute to groundbreaking research that may lead to improved prevention and treatment strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that acute compartment syndrome requires quick treatment, usually with surgery. Without surgery, it can seriously damage muscles and nerves. The surgery, called a fasciotomy, might reduce muscle strength in the affected leg. While this addresses the immediate danger, some long-term issues might still occur.
For exertional compartment syndrome, which arises with exercise, surgery is also an option. Studies indicate that about 7% of patients might need another surgery, and 5% could experience complications. Some people continue to feel pain during exercise even after treatment. Satisfaction with surgery varies widely, from 42% to 94%, and the ability to return to sports ranges from 26% to 100%.
Evidence suggests that both conditions carry known risks and possible long-term effects. However, these treatments are generally necessary to prevent more serious problems.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to uncover the role of gene expression in different types of compartment syndrome. Unlike standard treatments, which typically involve surgical intervention to relieve pressure, this study explores the underlying genetic factors that might influence the development of compartment syndrome. Understanding these genetic markers could lead to earlier diagnosis, more targeted therapies, and prevent the need for invasive procedures. By identifying specific gene expressions associated with acute and exertional compartment syndromes, this trial has the potential to revolutionize how these conditions are treated in the future.
What evidence suggests that this trial's treatments could be effective for compartment syndrome?
This trial will study different types of compartment syndrome. Research has shown that for sudden injuries with compartment syndrome, improving tissue energy use can help reduce muscle damage from poor blood flow. Studies have found that certain injuries, like crush injuries, increase the risk of this condition. Participants in this trial with acute tibial fractures and compartment syndrome will be observed for these effects.
In cases of exertional compartment syndrome, a surgery called fasciotomy, which relieves pressure, greatly reduces pain and increases satisfaction for most patients. Over 84% of those treated return to sports. Participants with exertional compartment syndrome in this trial will undergo this surgical procedure. Each condition has its own treatment methods, but evidence supports their effectiveness in managing symptoms and improving outcomes.678910Who Is on the Research Team?
Justin Haller, M.D.
Principal Investigator
University of Utah Orthopaedics
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 18 with lower leg injuries at risk of compartment syndrome. It includes those planning surgery for exertional compartment syndrome and patients with acute compartment syndrome from tibial fractures, as well as a control group without the syndrome.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Tissue Harvesting
Muscle tissue is harvested for analysis of myostatin levels and gene expression profiles
Follow-up
Participants are monitored for safety and effectiveness after tissue harvesting
What Are the Treatments Tested in This Trial?
Interventions
- Acute injury with compartment syndrome
- Acute injury without compartment syndrome
- Exertional compartment syndrome
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor